Skip to main content

Table 6 Number (%) of patients intolerant of each dose, safety population (n = 60)

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Dose (mg) Number of patients on this dose at any time, with data available on tolerabilitya Number (% of n) of patients intolerant of this dose at any time
10 55 1 (1.8)
20 54 3 (5.6)
30 47 2 (4.3)
35 41 3 (7.3)
40 34 1 (2.9)
45 32 4 (12.5)
50 31 8 (25.8)
  1. a Reduced numbers are as a result of patient withdrawals. Additionally, some patients titrated more slowly up the doses or never reached the higher doses.